Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Pediatric Endocrinology · Central Precocious Puberty

How Is Being Born SGA Linked to Central Precocious Puberty?

At a Glance

Being born small for gestational age does not by itself cause central precocious puberty. Rapid catch-up growth is linked with slightly earlier puberty in girls, while SGA plus short stature, low muscle tone, feeding problems, or a family history of early puberty may prompt genetic evaluation.

Being born Small for Gestational Age (SGA)—meaning a baby’s birth weight or length was below the expected percentile for their gestational age (weeks of pregnancy)—is connected to central precocious puberty (CPP) in two distinct ways.

First, there is a broad population trend where girls born SGA who experience rapid infant weight gain tend to start puberty slightly earlier [1] [2]. Second, an SGA history can serve as one contextual clue that, when combined with other specific physical signs or family history, may increase a doctor’s suspicion of rare genetic or epigenetic (how genes are regulated) conditions, such as Temple syndrome or DLK1 gene mutations [3] [4].

It is important to know that most children born SGA do not have a rare genetic syndrome. However, understanding this birth history helps your pediatric endocrinologist determine the most appropriate evaluation pathway.

Standard Evaluation for Early Puberty

Central precocious puberty (CPP) occurs when the brain signals the body to start puberty abnormally early (before age 8 in girls). When a child shows early signs of puberty, standard evaluation is warranted regardless of birth weight. This evaluation does not assume a rare genetic cause; instead, it looks to confirm whether the brain’s puberty signals are active.

The evaluation typically involves a physical exam, reviewing the child’s growth velocity over time, checking bone age (an X-ray of the hand and wrist to estimate skeletal maturity), and measuring hormones like luteinizing hormone (LH) and estradiol [5] [6]. Being born SGA does not change the basic interpretation of these standard test results, but it adds context to the broader diagnostic picture.

The General Link: SGA and Catch-Up Growth

Research shows an observational association between birth weight, infant growth, and pubertal timing. Girls who are born SGA and undergo rapid “catch-up” weight gain during their first months or years of life tend to experience an earlier average onset of puberty and menstruation compared to girls born at an average weight [1] [2].

While this trend is well-documented, rapid catch-up growth does not mean a child will automatically develop central precocious puberty, and this history alone cannot determine the precise cause of an individual child’s early puberty.

When SGA Acts as a Clue for Rare Conditions

If a child with early puberty was born SGA and also has persistent short stature, unusual body fat distribution, early feeding problems, low muscle tone (hypotonia), or a strong family history of early puberty, doctors may consider rare conditions related to a specific chromosomal region (14q32) [3] [4].

  • Temple Syndrome: This is an imprinting disorder, meaning the expression of certain genes is abnormally regulated depending on which parent they were inherited from. It is typically characterized by prenatal growth restriction (being born SGA), continuing short stature after birth, hypotonia, and feeding difficulties in infancy [7] [4] [8]. Early puberty is frequently reported in Temple syndrome, with studies of specific clinical cohorts observing early or central puberty in roughly 62% to 89% of affected patients, though these estimates come from small groups and can vary [7] [9] [4].
  • DLK1 Gene Mutations: DLK1 is a gene located in the same 14q32 region. Pathogenic variants (mutations) in this gene can cause a distinct form of familial central precocious puberty [10] [11]. While DLK1 mutations do not share all the physical features of Temple syndrome, some affected individuals were born SGA or develop early metabolic changes like increased body fat [3] [12]. Because of how this gene is imprinted, the condition is usually inherited from the father, though variants can also be de novo (new to the child, not inherited) [10] [13].

Understanding the Differences

Condition Common Features When is Genetic Evaluation Considered?
Typical SGA & Catch-Up Growth Born SGA, rapid infant weight gain, slightly earlier average puberty. Not routinely recommended without other syndromic signs or strong family history.
Temple Syndrome Born SGA, persistent short stature, feeding issues, hypotonia, very early puberty. When early puberty is paired with marked short stature, hypotonia, or other syndromic features.
DLK1 Mutations Early puberty, sometimes born SGA or with early changes in body fat; strong paternal family history. When there is a family history of early puberty (especially paternal), or other specific clinical signs.

How This Affects Evaluation and Care

Genetic testing is not routine for every child born SGA who develops central precocious puberty. However, if a child has additional syndromic features or a relevant family history, an endocrinologist may recommend referring the family to a genetics professional. Diagnosing Temple syndrome requires specialized testing that looks at how genes are methylated in the 14q32 region, rather than a standard genetic panel [4] [14]. DLK1 and another paternally expressed gene, MKRN3, are generally assessed through targeted gene panels [3] [15].

Finding a genetic explanation does not mean the evaluation failed, nor does it necessarily change the primary treatment for progressive central precocious puberty, which is often a GnRH-agonist medication used to temporarily pause puberty [16] [17]. However, a genetic diagnosis can significantly change how the care team monitors the child for other issues over time, such as growth, metabolism, and development, and provides critical information for family counseling.

Preparing for Your Appointment

To help your doctor evaluate whether your child’s SGA history is clinically significant, bring the following to your appointment:

  • Your child’s birth and neonatal records (including birth weight, length, and weeks of gestation).
  • A timeline of her height and weight measurements from infancy to the present.
  • A timeline of when pubertal signs (like breast development or body odor) first appeared and how they have changed.
  • Any known family history of early puberty, short stature, or metabolic issues, particularly on the biological father’s side.

Common questions in this guide

Does being born SGA mean my child will develop central precocious puberty?
No. Most children born small for gestational age do not develop central precocious puberty. Girls who have rapid catch-up weight gain may begin puberty somewhat earlier on average, but an SGA history alone cannot predict or explain an individual child's early puberty.
Why might SGA matter when a girl shows signs of early puberty?
SGA is one piece of a child's growth history, not a diagnosis. When it occurs with persistent short stature, feeding difficulties, low muscle tone, unusual body fat distribution, or a family history of early puberty, it may lead the endocrinologist to consider conditions such as Temple syndrome or DLK1-related puberty.
What evaluation does a child born SGA need for suspected central precocious puberty?
The usual evaluation includes a physical examination, review of growth over time, a bone-age hand and wrist X-ray, and hormone testing such as luteinizing hormone and estradiol. Being born SGA adds context but does not replace or fundamentally change the standard assessment.
When should genetic testing be considered for early puberty after SGA?
Genetic evaluation may be considered when early or central puberty occurs with marked short stature, low muscle tone, feeding problems, unusual fat distribution, or a strong family history, especially on the biological father's side. Temple syndrome is evaluated with specialized methylation testing, while DLK1 and MKRN3 are generally assessed with targeted genetic testing.
What are Temple syndrome and DLK1 mutations, and how are they linked to early puberty?
Temple syndrome is an imprinting disorder associated with growth restriction before birth, persistent short stature, low muscle tone, feeding difficulties, and frequent early puberty. Changes in the DLK1 gene can cause a familial form of central precocious puberty and may be associated with being born SGA or early increases in body fat.
Would a genetic diagnosis change my child's treatment for central precocious puberty?
A genetic diagnosis does not necessarily change the primary treatment for progressive central precocious puberty, which often uses a GnRH-agonist medicine to temporarily pause puberty. It can change longer-term monitoring of growth, metabolism, and development and provide information for family counseling.

Get notified when new evidence is published on Genetic central precocious puberty in female.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Size at birth, infant growth, and age at pubertal development in boys and girls.

    Hvidt JJ, Brix N, Ernst A, et al.

    Clinical epidemiology 2019; (11()):873-883 doi:10.2147/CLEP.S217388.

    PMID: 31572017
  2. 2

    Catch-Up Growth as a Risk Factor for Rapid Weight Gain, Earlier Menarche and Earlier Pubertal Growth Spurt in Girls Born Small for Gestational Age (SGA)-A Longitudinal Study.

    Durda-Masny M, Stróżewska W, Szwed A

    International journal of environmental research and public health 2022; (19(24)) doi:10.3390/ijerph192416808.

    PMID: 36554686
  3. 3

    Comprehensive Study on Central Precocious Puberty: Molecular and Clinical Analyses in 90 Patients.

    Narusawa H, Ogawa T, Yagasaki H, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(4)):1023-1036 doi:10.1210/clinem/dgae666.

    PMID: 39324648
  4. 4

    Temple Syndrome: Clinical Findings, Body Composition and Cognition in 15 Patients.

    Juriaans AF, Kerkhof GF, Mahabier EF, et al.

    Journal of clinical medicine 2022; (11(21)) doi:10.3390/jcm11216289.

    PMID: 36362517
  5. 5

    Diagnosis and management of precocious sexual maturation: an updated review.

    Cheuiche AV, da Silveira LG, de Paula LCP, et al.

    European journal of pediatrics 2021; (180(10)):3073-3087 doi:10.1007/s00431-021-04022-1.

    PMID: 33745030
  6. 6

    Diagnosis of Central Precocious Puberty.

    Bangalore Krishna K, Silverman LA

    Endocrinology and metabolism clinics of North America 2024; (53(2)):217-227 doi:10.1016/j.ecl.2024.02.002.

    PMID: 38677865
  7. 7

    Temple Syndrome: Comprehensive Clinical Study in Genetically Confirmed 60 Japanese Patients.

    Ogawa T, Narusawa H, Nagasaki K, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(9)):e3041-e3051 doi:10.1210/clinem/dgae883.

    PMID: 39693239
  8. 8

    Molecular and clinical studies in 8 patients with Temple syndrome.

    Gillessen-Kaesbach G, Albrecht B, Eggermann T, et al.

    Clinical genetics 2018; (93(6)):1179-1188 doi:10.1111/cge.13244.

    PMID: 29468661
  9. 9

    Temple syndrome - an under-recognised multi-system growth disorder: large cohort analysis and proposed scoring system.

    Juriaans AF, Gazdagh G, Temple IK, et al.

    The Journal of clinical endocrinology and metabolism 2026; doi:10.1210/clinem/dgag327.

    PMID: 42576450
  10. 10

    Paternally Inherited DLK1 Deletion Associated With Familial Central Precocious Puberty.

    Dauber A, Cunha-Silva M, Macedo DB, et al.

    The Journal of clinical endocrinology and metabolism 2017; (102(5)):1557-1567 doi:10.1210/jc.2016-3677.

    PMID: 28324015
  11. 11

    DLK1 Is a Novel Link Between Reproduction and Metabolism.

    Gomes LG, Cunha-Silva M, Crespo RP, et al.

    The Journal of clinical endocrinology and metabolism 2019; (104(6)):2112-2120 doi:10.1210/jc.2018-02010.

    PMID: 30462238
  12. 12

    Novel 14q32.2 paternal deletion encompassing the whole DLK1 gene associated with Temple syndrome.

    Baena N, Monk D, Aguilera C, et al.

    Clinical epigenetics 2024; (16(1)):62 doi:10.1186/s13148-024-01652-8.

    PMID: 38715103
  13. 13

    Idiopathic central precocious puberty with Prader-Willi syndrome: pubertal development with discontinuation of gonadotropin-releasing hormone analog.

    Kobayashi M, Yagasaki H, Tamaru K, et al.

    Endocrinology, diabetes & metabolism case reports 2022; (2022()).

    PMID: 36017812
  14. 14

    Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients.

    Kagami M, Nagasaki K, Kosaki R, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(12)):1356-1366 doi:10.1038/gim.2017.53.

    PMID: 28640239
  15. 15

    Genetics and Epigenetics of Human Pubertal Timing: The Contribution of Genes Associated With Central Precocious Puberty.

    Canton APM, Macedo DB, Abreu AP, Latronico AC

    Journal of the Endocrine Society 2025; (9(2)):bvae228 doi:10.1210/jendso/bvae228.

    PMID: 39839367
  16. 16

    A new DLK1 defect in a family with idiopathic central precocious puberty: elucidation of the male phenotype.

    Palumbo S, Cirillo G, Sanchez G, et al.

    Journal of endocrinological investigation 2023; (46(6)):1233-1240 doi:10.1007/s40618-022-01997-y.

    PMID: 36577869
  17. 17

    Chinese familial central precocious puberty with hyperuricemia due to recurrent DLK1 mutation: Case report and review of the literature.

    Yuan G, Zhang X, Liu S, Chen T

    Molecular genetics & genomic medicine 2022; (10(12)):e2087 doi:10.1002/mgg3.2087.

    PMID: 36353763

This page is for informational purposes only and does not constitute medical advice. Your child’s pediatric endocrinologist and genetics team can interpret the SGA history, test results, and treatment options for your family.